about
Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Reasons for switching ART: Comparison of data collected in 2012-2013 and 2014-2015 in Florence, Italy.Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART.The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD).
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Switch strategies in antiretroviral therapy regimens.
@en
type
label
Switch strategies in antiretroviral therapy regimens.
@en
prefLabel
Switch strategies in antiretroviral therapy regimens.
@en
P2860
P1476
Switch strategies in antiretroviral therapy regimens.
@en
P2093
Daniel Podzamczer
Eva Van den Eynde
P2860
P304
P356
10.1586/14787210.2014.944506
P577
2014-07-30T00:00:00Z